GR3006814T3 - - Google Patents

Info

Publication number
GR3006814T3
GR3006814T3 GR930400069T GR930400069T GR3006814T3 GR 3006814 T3 GR3006814 T3 GR 3006814T3 GR 930400069 T GR930400069 T GR 930400069T GR 930400069 T GR930400069 T GR 930400069T GR 3006814 T3 GR3006814 T3 GR 3006814T3
Authority
GR
Greece
Prior art keywords
heparin
humans
per cent
dosage
effective
Prior art date
Application number
GR930400069T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006814T3 publication Critical patent/GR3006814T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Soil Working Implements (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR930400069T 1986-06-26 1993-01-14 GR3006814T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (1)

Publication Number Publication Date
GR3006814T3 true GR3006814T3 (enExample) 1993-06-30

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400069T GR3006814T3 (enExample) 1986-06-26 1993-01-14

Country Status (10)

Country Link
EP (1) EP0251134B1 (enExample)
JP (1) JP2527749B2 (enExample)
AT (1) ATE82502T1 (enExample)
AU (1) AU608228B2 (enExample)
DE (1) DE3782686T2 (enExample)
DK (1) DK169422B1 (enExample)
ES (1) ES2052514T3 (enExample)
GR (1) GR3006814T3 (enExample)
IL (1) IL79254A0 (enExample)
NO (1) NO872675L (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
KR100571010B1 (ko) * 1997-07-14 2006-04-13 무라마쯔 다카시 미드카인 또는 그 저해제를 유효성분으로 하는 약제
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
CA2457719C (en) 2001-09-12 2012-01-03 Benito Casu Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
PT1748781E (pt) 2004-05-27 2013-01-22 Baxter Int Processos para o tratamento de distúrbios de hemorragias utilizando polissacarídeos sulfatados
CA2731304C (en) 2008-08-22 2017-06-06 Baxter Healthcare S.A. Methods for treating bleeding disorders using non-anticoagulant sulfated polysaccharides
AU2011205271B2 (en) 2010-01-14 2014-01-30 Baxalta GmbH Methods and compositions for treating bleeding disorders
US8846620B2 (en) 2011-07-19 2014-09-30 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
EP3594686A3 (en) 2012-08-14 2020-04-08 Baxalta GmbH Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
JP6377121B2 (ja) 2013-03-12 2018-08-22 バクサルタ インコーポレイテッド 低分子ヘパリンの経口製剤を改善するための添加剤としての吸収エンハンサ
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
CA2986974C (en) * 2015-06-11 2023-08-15 Universiteit Maastricht Method for preventing transplant failure in a host

Also Published As

Publication number Publication date
DK331287D0 (da) 1987-06-26
ATE82502T1 (de) 1992-12-15
JPS6388127A (ja) 1988-04-19
DE3782686T2 (de) 1993-06-09
DK331287A (da) 1987-12-27
IL79254A0 (en) 1986-09-30
AU608228B2 (en) 1991-03-28
EP0251134B1 (en) 1992-11-19
EP0251134A2 (en) 1988-01-07
JP2527749B2 (ja) 1996-08-28
EP0251134A3 (en) 1989-05-03
NO872675D0 (no) 1987-06-25
DE3782686D1 (de) 1992-12-24
AU7470687A (en) 1988-01-07
NO872675L (no) 1987-12-28
DK169422B1 (da) 1994-10-31
ES2052514T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
GR3006814T3 (enExample)
ZA858676B (en) Method and system for removing immunosppressive components from the blood of mammals
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
GR79015B (enExample)
ATE190496T1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
NZ210275A (en) Modified hirudin and its antithrombin properties
DE3167338D1 (en) Stabilisation of factor viii activity in blood plasma
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
EP0011651A4 (en) Pharmaceutical preparation containing 3-oxo-2,3-dihydro (1) -benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of caridovascular disorders.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
ES8602041A1 (es) Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada.
EP0058397A3 (en) Anticoagulant and the use thereof
ZA9010080B (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
WO1992004359A3 (en) Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
FI873429A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
DE3270466D1 (en) Pharmaceutical composition